Showing 3491-3500 of 23187 results for "".
Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 1
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-1/54619/In the first installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, discuss the rationale behind studying adjuvant skincare and the often-overlooked role of barrier repair in psoriasis management.1 Draelos Z, HougeiTROP2-Directed ADCs in Breast Cancer
https://reachmd.com/programs/cme/trop2-directed-adcs-in-breast-cancer/13882/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
https://reachmd.com/programs/neurofrontiers/gfap-and-vegf-trajectories-in-adult-type-3-spinal-muscular-atrophy-under-nusinersen/54637/DWTV Extra: GPP Awareness Day
https://reachmd.com/series/dermwire-tv/dwtv-extra-gpp-awareness-day/36704/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, discusses the importance of educating more clinicians about generalized pustular psoriasis (GPP) and observing GPP Awareness Day on August 13.Passion for Passing on Knowledge
https://reachmd.com/ma-issues-index/july-august-2025/sebastian-cotofana-facial-anatomy-education-platform-injector/36661/Renowned researcher gives back through online educationDupilumab in Preschool Atopic Dermatitis: Real-World Data on Efficacy and Safety
https://reachmd.com/programs/dermconsult/dupilumab-in-preschool-atopic-dermatitis-real-world-data-on-efficacy-and-safety/35497/Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
https://reachmd.com/programs/frontlines-prostate-cancer/evolving-treatment-patterns-in-mhspc-shifts-in-arpi-and-triplet-use/32218/Based on a recent analysis of over 10,000 patients from the Komodo claims database, there’s currently a shift toward using combination therapies—particularly AR pathway inhibitors (ARPis) with or without docetaxel—to treat patients with metastatic hormone-sensitive prostate cancer (mHSPC). Here to dDWTV Extra: New Tapinarof Data for AD
https://reachmd.com/series/dermwire-tv/dwtv-extra-new-tapinarof-data-for-ad/33940/Linda Stein Gold, MD, discusses the results from the Phase 3 ADORING 3 open-label, long-term extension study evaluating tapinarof cream, 1% once daily in children as young as 2 and adults with atopic dermatitis, presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in OrlandoThe Impact of Clascoterone Topical Cream, 1%: The US Experience 4 Years After Approval and Clinical Expectations for Acne Patients in Other Regions of the World
https://reachmd.com/topics/acne-rosacea/Impact-Clascoterone-Topical-Cream/32830/Clascoterone topical cream, 1% (Winlevi), approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older. The safety and efficacy were supported by two succeThe Society of Family Planning’s New Clinical Recommendations for Medication Abortion
https://reachmd.com/programs/advances-in-womens-health/the-society-of-family-plannings-new-clinical-recommendations/16166/Read more for an overview of the Society of Family Planning’s new clinical recommendations on medication abortion and hemorrhage.